DarioHealth shareholders approve up to 51.7M share issuance and warrant repricing

DarioHealth Corp.

Vote passed 21.4M for, 0.44M against, 0.08M abstain at special meeting on April 28, 2025.
Authorizes conversion of 25,605 Series D-3 preferred shares into 33.96M common shares from Dec 2024/Jan 2025 private placements.
Also authorizes up to 13.58M common shares as dividends on Series D-3 preferred and up to 4.18M shares for lock-up agreements with B/C preferred holders.
Warrant repricing: 584,882 warrants to Avenue at $0.7208/share; loan conversion up to $2M at $0.8650/share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.